Novo Nordisk: The Management of Obesity for Appropriate Individuals: Questions, Answers and Resources

Recently, there has been significant interest in anti-obesity medications (AOMs) from the general public, employers, and access stakeholders. In an effort to provide decision-makers like you with information you may need when considering a weight-management approach for your employees or members, we have created these sample Q&As. The topics covered include:

  • Part 1: Impact of Weight Loss
  • Part 2: AOMs for the Treatment of Obesity or Overweight
    • Section 1: Your Population and AOMs
    • Section 2: The Evolution of AOM Coverage
    • Section 3: Integrating AOMs Into Your Organization’s Weight-Management Approach

Obesity and associated comorbidities are a prevalent and costly chronic condition that can impact the health of your employees and your organization. Novo Nordisk recognizes the challenges in the workplace created by obesity and aims to help employers understand the value of chronic weight management

Latest Posts
Partner News
An ROI Study of Modern Health’s Adaptive Care Model for Mental Health Prevention and Treatment
Organizations often focus on responding to the most urgent mental health needs.  Modern Health’s ROI ...
Read More
Partner News
Espresa: Wellbeing that Works – How Flexible Benefits Drive Real Engagement
Today’s workforce is stretched thin—balancing caregiving, health, and daily life before the workday begins. It’s ...
Read More
Partner News
WTW: Employer Role in Preventing Cardiovascular Disease
Mortality from heart disease declined in the US between 1980 and 2010 due to the ...
Read More
Follow SVEF
Scroll to Top

Join the Mailing List

Contact the Team

This field is for validation purposes and should be left unchanged.
Name(Required)